Aging is associated with learning deficits and a decrease in neuronal excitability, reflected by an enhanced post-burst afterhyperpolarization (AHP), in CA1 hippocampal pyramidal neurons. To identify the current(s) underlying the AHP altered in aging neurons, whole-cell voltage-clamp recording experiments were performed in hippocampal slices from young and aging rabbits. Similar to previous reports, aging neurons were found to rest at more hyperpolarized potentials and have larger AHPs than young neurons. Given that compounds that reduce the slow outward calcium-activated potassium current (s I AHP ), a major constituent of the AHP, also facilitate learning in aging animals, the sI AHP was pharmacologically isolated and characterized. Aging neurons were found to have an enhanced sI AHP, the amplitude of which was significantly correlated to the amplitude of the AHP (r ϭ 0.63; p Ͻ 0.001). Thus, an enhanced sI AHP contributes to the enhanced AHP in aging. No differences were found in the membrane resistance, capacitance, or kinetic and voltage-dependent properties of the sI AHP . Because enhanced AHP in aging neurons has been hypothesized to be secondary to an enhanced Ca 2ϩ influx via the voltage-gated L-type Ca 2ϩ channels, we further examined the sI AHP in the presence of an L-type Ca 2ϩ channel blocker, nimodipine (10 M). Nimodipine caused quantitatively greater reductions in the sI AHP in aging neurons than in young neurons; however, the residual sI AHP was still significantly larger in aging neurons than in young neurons. Our data, in conjunction with previous studies showing a correlation between the AHP and learning, suggest that the enhancement of the sI AHP in aging is a mechanism that contributes to age-related learning deficits.
Action potentials in hippocampal pyramidal neurons are followed by a post-burst afterhyperpolarization (AHP), which serves to limit further firing in response to sustained excitation in a process known as spike frequency adaptation (accommodation). Reductions in the AHP and accommodation have been observed in neurons from animals trained in various hippocampus-dependent (Moyer et al., , 2000 Thompson et al., 1996b; Oh et al., 2001) and non-hippocampus-dependent tasks (Disterhoft et al., 1986; Coulter et al., 1989; Saar et al., 1998) , suggesting that it is a general mechanism to increase neuronal excitability in learning.
The AHP and accommodation are reduced after the acquisition of the hippocampus-dependent trace eyeblink conditioning task in CA1 and CA3 hippocampal pyramidal neurons (Moyer et al., , 2000 Thompson et al., 1996b) . These biophysical changes are most likely learning induced, because they are not observed in neurons of pseudoconditioned controls (which receive the same but unpaired stimuli), naive controls, and animals that failed to acquire the task. Furthermore, reductions in the AHP and accommodation return to baseline in 7 d Thompson et al., 1996b) , consistent with the hypothesis that the hippocampus functions as an intermediate storage buffer during learning (Cohen and Eichenbaum, 1993; Kim et al., 1995; Disterhoft et al., 1996) .
Acquisition of the trace eyeblink conditioned response is impaired in aging animals and aging humans (Thompson et al., 1996a; Weiss et al., 2000; Knuttinen et al., 2001a,b) . Interestingly, the AHP and accommodation are enhanced in CA1 neurons from animals at ages that show learning deficits (Landfield and Pitler, 1984; Moyer et al., 1992 Moyer et al., , 2000 . Although many aging animals failed to acquire the trace eyeblink conditioned response (Thompson et al., 1996a) , those that did learn also showed a reduction in the AHP (Moyer et al., 2000) . This inverse correlation between the AHP and learning has led us to hypothesize that AHP enhancement in aging is a mechanism involved in agerelated learning deficits. Consistent with our hypothesis, drugs that reduce the AHP in vitro have also been shown to improve learning in aging animals (Deyo et al., 1989; Moyer et al., 1992; Kronforst-Collins et al., 1997; Oh et al., 1999; Weiss et al., 2000 , Power et al., 2001 .
The AHP is mediated by four outward K ϩ currents (I C , I M , I AHP , and sI AHP ), and its time course is modulated by the hyperpolarization-activated current, I h (Storm, 1990; Maccaferri et al., 1993; Stocker et al., 1999; Oh et al., 2000) . Given the kinetics of these currents, previous experiments showing prolonged AHP and enhanced accommodation in aging neurons strongly implicate alterations in the slower currents, particularly the sI AHP , in aging (Landfield and Pitler, 1984; Moyer et al., 1992 Moyer et al., , 2000 Power et al., 2001 ). The following experiments were undertaken to determine whether the I AHP -sI AHP contributes to the enhanced AHP in aging neurons.
MATERIALS AND METHODS
Subjects. Young (2-3 months old) and aging (Ͼ36 months old) female New Z ealand albino rabbits (Or yctolagus cuniculus) were chosen as subjects. Animal use procedures were approved by Northwestern University's Animal C are and Use Committee, according to the standards of the United States Department of Agriculture.
Slice preparation. Slices were prepared following procedures similar to those described previously . Briefly, two bathing solutions were used during the dissection: (1) normal artificial C SF (aC SF) composed of (in mM): 124 NaC l, 3 KC l, 1.3 MgSO 4 , 1.24 NaH 2 PO 4 , 2.4 CaCl 2 , 26 NaHC O 3 , 10 D-glucose, and (2) sucrose -aC SF, containing an equiosmolar concentration of sucrose in place of NaC l. Both normal -and sucrose -aC SF solutions were oxygenated (bubbled with 95% O 2 -5% C O 2 , pH 7.4).
Rabbits were anesthetized with halothane and killed by decapitation. The brain was rapidly exposed in situ, hemisected, removed within 60 sec, and immediately immersed in oxygenated ice-cold (Ͻ1°C) sucroseaC SF for ϳ4 min. Both hippocampi were quickly dissected out, cut into 3-4 mm chunks, and glued onto chilled chambers that were then filled with ice-cold sucrose -aC SF. Transverse slices (300 M) along the dorsalventral gradient of the hippocampus were prepared using Vibratomes (TPI, O'Fallon, MO) and placed in holding chambers filled with normalaC SF at room temperature (ϳ23°C) for at least 45 min before any experiment.
W hole-cell electrodes and solutions. Patch electrodes were made from borosilicate glass using a Sutter Flaming-Brown horizontal puller (P-87; Sutter Instrument Company, Novato, CA) and heat-polished with a Narishige microforge (Model M F-930; Narishige International USA, Inc., East Meadow, N Y) to a resistance of 1.5-6.0 M⍀. Three pipette solutions were used and consisted of the following (in mM): (1) 2 K-ATP, 10 H EPES, and 150 K MeSO 4 ; (2) 2 K-ATP, 10 H EPES, 140 K MeSO 4 , and 10 KC l; and (3) 2 K-ATP, 10 H EPES, 130 K MeSO 4 , and 10 KC l. The pH of these solutions was adjusted to 7.25 with KOH; the osmolarity of these solutions was 290 Ϯ 10 mOsm. The results obtained with these solutions were indistinguishable. MeSO 4 Ϫ was used in place of C l Ϫ to reduce the rundown of the AHP current over time (Z hang et al., 1994) . The use of K MeSO 4 in the electrode solution resulted in a ϳ10 mV junction potential with respect to the aC SF. This junction potential was measured for every batch of electrode solution according to procedures published by Neher (1992) and was corrected before data acquisition.
Data anal ysis and cell criteria. Hippocampal neurons were visualized using either a Z eiss Axioskop (C arl Z eiss, Inc., Oberkochen, Germany) or a Leica DM L FS microscope (Leica Microsystems AG, Wetzlar, Germany); both were equipped with a long working distance 40ϫ water immersion objective and infrared differential interference contrast optics (Dodt and Z ieglansberger, 1990; Stuart et al. 1993) .
T wo data acquisition systems were developed using either LabV I EW (National Instrument, Austin, TX) or Cϩϩ Builder (Borland Software Corporation, Scotts Valley, CA) with National Instrument N I DAQ driver. Data were acquired at 5 kHz and filtered at 2 kHz using a low-pass Bessel filter. Whole-cell recording procedures for young and aging neurons were variants of previously published procedures, using a single pipette to "clean" and patch onto the neuron (Blanton et al., 1989) . Recordings were made from the soma of visually identified CA1 pyramidal neurons with seal resistances Ͼ1.5 G⍀ before break through into the whole-cell mode. A few cells were labeled with L ucifer yellow to monitor the equilibration between the intracellular milieu and the pipette solution. All measurements were made at least 10 min after membrane rupture to allow for adequate solution equilibration. Only neurons with series resistance Ͻ15 M⍀, membrane resistance Ͼ60 M⍀, resting potential less than Ϫ60 mV, and for current-clamp recordings action potential amplitude Ͼ90 mV from resting potential were included in the data set.
Current-clamp protocols. The AHP was first measured in current-clamp mode to provide a direct comparison for previous studies. Subsequently, the I AHP -sI AHP was pharmacologically isolated and characterized in voltage-clamp mode. Slices were individually transferred to small glassbottom recording chambers and perf used continuously (ϳ2 ml /min) with oxygenated aC SF heated to 31°C. Our laboratory has evidence for a dorsal-ventral gradient in excitability within the hippocampus . Thus, slices equally distributed across the septotemporal axis of the hippocampus in both age groups were used for recording. During current-clamp recordings, a membrane potential of neurons was maintained at Ϫ68 mV with either hyperpolarizing or depolarizing current injection, and the AHP was evoked using a 100 msec depolarizing current step that reliably elicited a burst of four action potentials. The AHP measurements included the following: peak amplitude of the AHP (calculated as the maximum negative voltage deflection from the baseline potential during the first 250 msec after the current offset), duration of the AHP (measured as the time required for the membrane potential to return to the baseline potential for at least 10 msec after the 100 msec depolarizing current step offset), and integrated area of the AHP (calculated from the current offset for the entire duration of the AHP).
Voltage-clamp protocols. After current-clamp measurements, the I AHPsI AHP were isolated by bath perf usion of modified aC SF containing the following: 500 nM tetrodotoxin (TTX) to block Na ϩ current; 2 mM CsCl to block inward K ϩ currents and I h ; 2 mM 4-aminopyridine (4-AP) to block I A and I D ; 5 mM tetraethylammonium (TEA) to block I C and I M ; and 100 -500 M picrotoxin, and 2 mM kynurenic acid or 10 M 6-cyano-7-nitroquinoxaline-2,3-(1H,4H)-dione (C NQX), and 25 M D-2-amino-5-phosphonovaleric acid (D-AP5) to reduce synaptic current. 4-AP and TEA were substituted for equimolar NaC l. To block the L -type C a 2ϩ influx, nimodipine (dissolved in dimethyl sulfoxide) was added directly to the modified aC SF to achieve the desired concentration. Because nimodipine is light sensitive, all experiments involving nimodipine were performed in near-darkness. For all pharmacological experiments, slices were exposed to the modified medium for 10 -20 min before measurements were taken.
Although both the I AHP and sI AHP coexist in CA1 hippocampus, the I AHP accounts for only 20% of the AHP in rabbit CA1 pyramidal neurons . The apamin-sensitive I AHP has a relatively fast onset (1-5 msec) and a slow offset lasting between 50 and several hundred milliseconds (Sah, 1996; Stocker et al., 1999) . In contrast, the decay time constant of the sI AHP is ϳ1.5 sec (Sah, 1996) . Therefore, we differentiated the sI AHP from the I AHP by measuring the tail current 1 sec after pulse offset.
The AHP tail current was evoked by a 100 msec, 50 mV voltage step from a holding potential of Ϫ55 mV. This protocol elicited a single, robust, unclamped C a 2ϩ current followed by the AHP tail current. Although the membrane voltage was not precisely controlled during the depolarizing step because of the gain and space-clamp limitations, voltage control of the AHP tail current was well maintained (Lancaster and Adams, 1986; Constanti and Sim, 1987; Sah and McLachlan, 1991; Z hang et al., 1995) . The AHP tail current measurements included the following: peak amplitude, latency to peak amplitude, amplitude of the tail current at 200 msec, 1 sec, and 2 sec after pulse offset, and decay rate. The decay kinetics of the AHP current were determined by measuring the time it took for the current to decay to half of the 200 msec (half decay 200) and 800 msec amplitudes (half decay 800, which revealed the decay of the sI AHP alone). The decay time constant was also determined by fitting a single exponential to the tail current 400 -3000 msec after pulse offset.
The voltage dependence and reversal potential of sI AHP were examined by holding the neurons at Ϫ55 mV, activating the sI AHP by a 100 msec, 50 mV voltage step, and then varying the holding potential of the tail current from Ϫ45 to Ϫ95 mV (see Fig. 4 A) . The voltage-dependence of sI AHP activation was assessed by holding the neurons at Ϫ55 mV and varying the amplitude of a 100 msec step potential (see Fig. 3A ). The time dependence of sI AHP activation was assessed by holding the neurons at Ϫ55 mV and varying the duration of a 15-20 mV subthreshold activation pulse (see Fig. 3B ).
Data anal ysis. All statistical analyses were performed using Statview (SAS Institute Inc., C ary, NC). Correlations were tested using Fisher's r to z. Age-related differences in amplitudes were tested using ANOVA, unpaired t test, or Mann -Whitney U test as appropriate. The F test was used to test for age-related differences in the variance. Data are reported as the mean Ϯ SEM.
Drugs. K MeSO 4 was purchased from IC N (Aurora, OH); TTX was from C albiochem (San Diego, CA); D-AP5 and C NQX were from Tocris (Ellisville, MO). All other drugs were purchased from Sigma (St. L ouis, MO).
RESULTS
The age-related differences in the AHP and AHP currents are summarized in Table 1 . No difference was observed in the membrane resistance or membrane capacitance between the two age groups. Similar to our previous report (Moyer et al., 1992) , aging neurons rested at more hyperpolarized potentials (aging ϭ Ϫ75.9 Ϯ 1.2 mV; young ϭ Ϫ70.2 Ϯ 1.4 mV; p Ͻ 0.01) and exhibited greater AHP peak amplitudes (aging ϭ Ϫ9.03 Ϯ 0.64 mV; young ϭ -7.21 Ϯ 0.45 mV; p Ͻ 0.05) (Fig. 1) than young neurons. To control for resting membrane potential (RMP) differences, the neurons were maintained at Ϫ68 mV with either hyperpolarizing or depolarizing current injection, and the AHP was measured after a 100 msec current step that triggered four action potentials. The current used to hold the neurons at Ϫ68 mV was greater for aging neurons than for young neurons (aging ϭ 64 Ϯ 18 pA; young ϭ 6 Ϯ 15 pA; p Ͻ 0.05). Similarly, the current required to elicit four action potentials was greater for aging than for young neurons (aging ϭ 966 Ϯ 98 pA; young ϭ 682 Ϯ 52 pA; p Ͻ 0.01).
The current-clamp measurements of the AHP may be biased by differences in the depolarizing current pulse that may result in differences in Ca 2ϩ influx or subtle changes in other conductances that control spike broadening. Therefore, we characterized the currents underlying the slow AHP (I AHP -sI AHP ) with voltage-clamp protocols in the presence of Na ϩ and K ϩ channel blockers (TTX, CsCl, 4-AP, and TEA). Recordings of the AHP current also revealed an aging-related increase in the peak current amplitude (mixed I AHP -sI AHP amplitude; aging ϭ 604.7 Ϯ 66.2 pA; young ϭ 374.1 Ϯ 36.3 pA; p Ͻ 0.01), current amplitudes at 1 and 2 sec after pulse offset (sI AHP amplitudes; 1 sec: aging ϭ 325.9 Ϯ 39.5 pA; young ϭ 186.8 Ϯ 22.8 pA; p Ͻ 0.01; 2 sec: aging ϭ 206.2 Ϯ 30.9 pA; young ϭ 106.3 Ϯ 16.4 pA; p Ͻ0.01) (Fig. 2 A) , and integrated area of the tail current (aging ϭ 830.8 Ϯ 111.2 pC; young ϭ 486.9 Ϯ 57.8 pC; p Ͻ 0.01). The amplitude of the AHP showed correlations to all of the amplitude measurements, as well as the integrated area, of the AHP tail current ( Table 2 ), indicating that the enhancements in the I AHP and the sI AHP underlie the enhancement in the AHP in aging. Most of the amplitude measurements of the sI AHP showed a greater variance in aging neurons. Although no differences were observed in the peak latency and the decay of the AHP tail current, the time required for the tail current to decay to half its amplitude at 800 msec after pulse offset was significantly longer in aging neurons than in young neurons ( p Ͻ 0.05). Given that the apamin-insensitive, slow component of the AHP (the sI AHP ) accounts for ϳ80% of the total AHP in rabbit CA1 pyramidal neurons and outlasts the I AHP by seconds (Sah, 1996; Stocker et al., 1999) , the correlations between our currentclamp and voltage-clamp measurements suggest that the enhanced sI AHP predominantly underlies the enhanced AHP in aging neurons.
As step potentials were increased, a transient inward current appeared within a few milliseconds of pulse onset, followed by a slow outward current that continued as the AHP tail current. Increasing the amplitude of the step potential increased the amplitude of the sI AHP in both age groups . Although no clear-cut threshold of sI AHP activation could be determined, no significant tail current was observed unless the step potentials elicited an obvious Ca 2ϩ transient (Fig. 3A) . Increasing the duration of the step potential also increased the amplitude of sI AHP in both age groups (Fig. 3B) . The kinetics and voltage-dependence of the sI AHP were not different in both age groups; these values were consistent with previous recordings from young hippocampal pyramidal neurons (Lancaster and Adams, 1986) . The sI AHP showed little voltage dependence from Ϫ45 to Ϫ85 mV for both age groups (Fig. 4C) . Likewise, its decay rate was voltage independent (Fig. 4 B) . In both age groups, the sI AHP reversed at approximately Ϫ94 mV, suggesting that the enhancement in the sI AHP in aging was not caused by a change in the driving force for K ϩ . Our laboratory has reported previously that the AHP enhancement in aging is independent of the resting membrane potential difference (Moyer et al., 1992) . Likewise in this study, when we compared the sI AHP from cells with comparable resting membrane potentials (Ϫ82 mV Ͻ RMP Ͻ Ϫ77 mV), aging neurons still had significantly larger sI AHP than young neurons ( young ϭ 153.63 Ϯ 22.47 pA, n ϭ 14; aging ϭ 269.04 Ϯ 34.64 pA, n ϭ 14; p Ͻ 0.01). Thus, the difference in the resting membrane potentials did not contribute to the aging-related enhancement of the sI AHP .
The sI AHP is a Ca 2ϩ -dependent K ϩ current. Thus, its amplitude is affected by the amount of Ca 2ϩ available to cause channel activation. Previous reports have demonstrated an aging-related enhancement in voltage-gated Ca 2ϩ influx (Landfield and Pitler, 1984; Pitler and Landfield, 1990; Moyer and Disterhoft, 1994; Campbell et al., 1996) , partially attributable to an increase in the functional L-type Ca 2ϩ channel density Chen et al., 2000) , in neurons from aging animals. Furthermore, the enhancements in the AHP and the plateau phase of the Ca 2ϩ action potential in aging neurons are both reduced by nimodipine, an L-type Ca 2ϩ channel blocker (Moyer and Disterhoft, 1994) , raising a possibility that the enhanced sI AHP in aging neurons is secondary to an enhanced L-type Ca 2ϩ influx. To investigate whether age-related enhancement of the sI AHP is secondary to an enhanced L-type Ca 2ϩ influx, we examined the sI AHP before and after bath applications of nimodipine (10 M). Aging-related enhancement of the sI AHP ( p Ͻ 0.0005) was replicated and reported in Table 3 . Bath application of nimodipine significantly reduced the integrated area of the I AHP -sI AHP , as well as the amplitude of the sI AHP , at 1 sec after pulse offset ( p Ͻ0.0001) (Fig. 5) . Nimodipine reduced both the area of the I AHP -sI AHP and the amplitude of the sI AHP in young and aging neurons by Ͻ25 and Ͻ30%, respectively (Fig. 6 A) . Consistent with our previous study (Moyer and Disterhoft, 1994) , nimodipine caused quantitatively greater reductions in the integrated area of the I AHP -sI AHP and the amplitude of the sI AHP in aging A, An example of the sI AHP in response to depolarizing voltage steps from Ϫ50 to Ϫ10 mV, in increments of 10 mV. For leak subtraction, 2 mV step potentials were used. Note that although increasing the amplitude of the voltage pulse increased the amplitude of the sI AHP , no significant sI AHP was observed until an obvious Ca 2ϩ transient was elicited by the step potentials. B, Increasing the pulse duration also increased the amplitude of the sI AHP . The sI AHP was activated with depolarizing steps from Ϫ50 to Ϫ30 mV with varying durations. Voltage steps with longer durations allowed for more Ca 2ϩ influx, thereby increasing the sI AHP .
neurons than in young neurons ( p Ͻ0.05) (Fig. 6 B) . The residual area of the I AHP -sI AHP and the amplitude of the sI AHP were still significantly larger in aging neurons than in young neurons (amplitude for young ϭ 117.3 Ϯ 17.65 pA; for old, 190.0 Ϯ 21.47 pA; p ϭ 0.01) (Fig. 6C) . Hence, our data are consistent with observations of an enhanced L-type Ca 2ϩ influx in aging neurons. However, this enhanced L-type Ca 2ϩ influx cannot fully account for the aging-related enhancement in the sI AHP .
DISCUSSION
In hippocampal pyramidal neurons, excitability is controlled by a pronounced AHP. Based on kinetics and pharmacological criteria, the AHP can be separated into fast, medium, and slow components (for review, see Storm, 1990; Sah, 1996) . In neurons from trace eyeblink conditioned animals, both the peak amplitude of the AHP and its duration are decreased (Moyer et al., , 2000 Thompson et al., 1996b) . In contrast, both parameters are increased in neurons from naive aging animals (Landfield and Pitler, 1984; Moyer et al., 1992) . After pharmacologically isolating the slow components of the AHP (I AHP -sI AHP ), we found agerelated enhancements in the integrated area (mixed I AHP -sI-AHP ), the peak amplitude (mixed I AHP -sI AHP ), and the amplitudes at 1 and 2 sec after pulse offset (sI AHP alone) for the AHP tail current. We did not pharmacologically separate the I AHP and the sI AHP . However, in CA1 pyramidal neurons from rabbits and rats, the apamin-sensitive I AHP accounts for only a small percentage (ϳ20%) of the total AHP (Stocker et al., 1999; Oh et al., 2000) . Furthermore, blocking I AHP with saturating concentrations of apamin had only small effects on accommodation . Thus by inference, the reduced neuronal excitability observed in aging neurons can mostly be attributed to an enhanced sI AHP . Consistent with this hypothesis, the amplitude measurements of the sI AHP correlated with the integrated area, as well as amplitude measurements, of the AHP, further supporting the possibility that an enhanced sI AHP underlies an enhanced AHP in aging.
Many factors can lead to an enhanced sI AHP in aging. Increased leak conductance is not likely to be one of them, because neurons of both age groups shared similar membrane resistances. Although aging neurons rested at more hyperpolarizing potentials, the reversal potentials for the sI AHP were similar in both young and aging neurons. Furthermore, when the cells were grouped by resting membrane potentials, aging neurons still had significantly larger sI AHP than young neurons, suggesting that changes in the driving force for K ϩ ions do not contribute to an enhanced sI AHP in aging. The slow AHP is also affected by conductances that control spike broadening, and hence the amount of Ca 2ϩ influx, such as the A-type voltage-dependent K ϩ current (Giese et al., 1998) . The enhanced sI AHP that we observed in aging neurons is not caused by alterations in these conductances, because all voltage-clamp recordings were performed in the presence of 4-AP and TEA.
The sI AHP is a Ca 2ϩ -dependent K ϩ current that is modulated by many neurotransmitters. Therefore, its amplitude also depends on (1) the amount of Ca 2ϩ available to cause channel activation, (2) the degree of modulation, and (3) channel conductance and functional density of the sI AHP channels. Many studies have shown altered Ca 2ϩ homeostasis in aging neurons. Changes in voltage-gated Ca 2ϩ influx (Landfield and Pitler, 1984; Moyer et al., 1992; Thibault and Landfield, 1996) and intracellular Ca 2ϩ release (Martini et al., 1994) , as well as an elevation in the free cytosolic Ca 2ϩ concentration, most likely resulting from a combination of disrupted Ca 2ϩ handling, buffering, sequestration, and efflux mechanisms (Khachaturian, 1989; Disterhoft et al., 1993 Disterhoft et al., , 1994 Thibault et al., 1998; Verkhratsky and Toescu, 1998) , have all been implicated in aging. Exactly how these changes Figure 4 . Voltage independence and reversal potential of the AHP tail current. A, The protocol for measuring the voltage dependence of the sI AHP tail current. The sI AHP tail current was evoked by a 100 msec, 50 mV pulse from a holding potential of Ϫ55 mV. After the voltage pulse, membrane potential was stepped to various test potentials for 2 sec before returning to the Ϫ55 mV holding potential. For leak subtraction, the neurons were stepped to the test potentials for 2 sec without the 100 msec, 50 mV prepulse to elicit the sI AHP tail current. B, Representative currents evoked from the voltage-dependence protocol. C, The reversal potential was obtained by linear extrapolation of the voltage versus sI AHP amplitude at 1 sec to the voltage axis. The reversal potential of the sI AHP in this example was Ϫ90 mV. Similar to previous reports, the sI AHP conductance did not show any voltage dependence at either age ( young: n ϭ 7; aging: n ϭ 11). The test potentials did not alter the decay rate of the current, and amplitude of the sI AHP measured at 1 sec after the various test potentials (labeled as 3s and denoted with an arrow) remained the same. affect the sI AHP is unclear. For example, it has been hypothesized that the age-related enhancement of the AHP is secondary to an enhanced Ca 2ϩ influx (Pitler and Landfield, 1990) , particularly that through the L-type Ca 2ϩ channels (Campbell et al., 1996; Thibault and Landfield, 1996; Chen et al., 2000) . In this study, we addressed this possibility by examining the effect of nimodipine on the sI AHP in the context of aging. Saturating concentrations of nimodipine caused quantitatively greater reductions in the sI AHP in aging neurons than in young neurons, suggesting that the contribution of the L-type Ca 2ϩ influx to activate the sI AHP is enhanced in aging. However, after blocking the L-type Ca 2ϩ influx, the residual sI AHP from aging neurons remained significantly larger than that of the young neurons, indicating that the enhanced L-type Ca 2ϩ influx alone cannot account for the agingrelated enhancement of the sI AHP .
Although nimodipine is a highly lipophilic compound, and its diffusion through slices can be problematic, it is not likely that the enhanced sI AHP in aging neurons observed in the presence of nimodipine is caused by differences in the amount of unblocked L-type Ca 2ϩ currents. In this study, saturating concentrations of nimodipine were applied for at least 10 min before recording. In addition, recordings were typically made from CA1 pyramidal neurons at no more than 100 m below the surface of the slice.
Previously our laboratory has shown that the L-type Ca 2ϩ current in aging neurons can be blocked with lower concentrations of nimodipine than that of the young neuron (Moyer et al., 1992) . In the unlikely event of a diffusion problem, these data suggest a greater likelihood for residual L-type Ca 2ϩ current to exist in young neurons than in aging neurons. In such a case, the agingrelated enhancement of the sI AHP that is independent of the L-type Ca 2ϩ influx reported here would be an underestimation. Ca 2ϩ that activates the sI AHP also comes from intracellular Ca 2ϩ store release through a process known as Ca 2ϩ -induced Ca 2ϩ release (CICR) (Sah and McLachlan, 1991; Torres et al., 1995 Torres et al., , 1996 Tanabe et al., 1998; Shah and Haylett, 2000) . Whether altered CICR contributes to an enhanced sI AHP in aging remains speculative.
The amplitude of the sI AHP also depends on the degree of neuromodulation it receives. The sI AHP is reduced by metabotropic glutamate agonists (Liu et al., 1993) , acetylcholine (Madison et al., 1987) , serotonin (Colino and Halliwell, 1987) , histamine (Haas and Greene, 1986) , dopamine (Malenka and Nicoll, 1986) , noradrenaline (Haas and Konnerth, 1983; Madison and Nicoll, 1986) , corticotropin releasing factor (Fox and Gruol, 1993) , vasoactive intestinal peptide (Haas and Gahwiler, 1992) , and calcitonin gene-related peptide (Nohmi et al., 1986 ). Many of Amplitude and area of the AHP were correlated to amplitudes and area of the slow outward tail current. Correlations, r, were performed using Fisher's r to z. Significant effects are highlighted in bold. these molecules were shown to suppress the sI AHP through protein kinase activities (Gerber et al., 1992; Müller et al., 1992; Pedarzani and Storm 1993 , 1996 Torres et al., 1995; AbdulGhani et al., 1996; Haug and Storm, 2000) . Changes in many of these neurotransmitter systems (Luine et al., 1990; Fischer et al., 1992; Smith and Booze, 1995; Richter-Levin and Segal, 1996; Miguez et al., 1999; Stemmelin et al., 2000; Segovia et al., 2001) , as well as their effector kinases (Colombo et al., 1997; Pascale et al., 1998) , have been implicated in aging. Conceivably, altered neurotransmission in aging, coupled with altered kinase functions, can shift the balance between kinase and phosphatase activities that normally maintain the sI AHP (Pedarzani et al., Figure 5 . The effect of L-type Ca 2ϩ influx on the sI AHP . Shown are representative current traces from young and aging neurons before and after bath applications of nimodipine. Figure 6 . A, Bath application of nimodipine caused a comparable percentage (25-30%) of reduction in the sI AHP of young and aging neurons. B, The amount of reductions in the sI AHP (1 sec amplitude) and the AHP current (integrated area) was significantly larger in aging than in young neurons (unpaired t test; *p Ͻ 0.05 and **p Ͻ 0.001, respectively; n ϭ 31 for aging; n ϭ 25 for young). C, After eliminating the contribution of the L-type Ca 2ϩ influx on the sI AHP with bath-applied nimodipine, the residual sI AHP and AHP current were still significantly larger in the aging neurons than in the young neurons (unpaired t test; *p Ͻ0.05).
1998) and alter this current. The enhanced sI AHP in aging neurons that we report in this study is a postsynaptic phenomenon and does not reflect changes in basal neurotransmission, because our slices were perf used in aC SF containing TTX as well as glutamatergic and GABAergic antagonists.
Age-related changes in the functional sI AHP channel density as well as the channel properties can also affect the sI AHP . Whether these mechanisms contribute to the enhanced sI AHP in aging remains to be addressed.
Molecules that affect the sI AHP have also been implicated in other forms of plasticity. For example, kinases known to modulate the sI AHP (PKC, PKA, and calcium-calmodulin kinase II) are also important for the induction of long-term potentiation (LTP), a model for cellular mechanisms of learning and memory (for review, see Soderling and Derkach, 2000) . Currently, the sI AHP channels are thought to be located on apical or basal dendrites close to the soma (Sah and Bekkers, 1996; Bekkers, 2000) , although a recent study by Lancaster et al. (2001) questions the basal dendritic location, suggesting a role for the sI AHP in controlling dendritic excitability and synaptic integration (LoTurco et al., 1988; Andreasen and Lambert, 1995) . Consistent with this hypothesis, activation of the sI AHP dampens temporal summation of the EPSPs as well as speeds up their decay rate (Lancaster et al., 2001) . Pharmacological manipulations that facilitated LTP have also been shown to reduce the AHP (Cohen et al., 1999) , suggesting that the AHP and its underlying currents can serve as an adjustable gain control, variably hyperpolarizing and shunting synaptic potentials arising in the distal dendrites and controlling the induction of further plasticity (Sah and Bekkers, 1996) . Accordingly, the enhanced sI AHP in aging can hamper the formation of further plastic alterations important for learning and memory (Dunwiddie et al., 1992; Sah and Bekkers, 1996; Giese et al., 2001) .
The correlation between the AHP (and thus, accommodation) and learning have led us to hypothesize that the enhancement in the AHP is involved in aging-related memory deficits. Here we report that this AHP enhancement in aging is attributable to an enhanced sI AHP . In addition, the variance of the sI AHP amplitude increases with age, strikingly similar to the age-related heterogeneity of learning observed in rabbits of the same age (Thompson et al., 1996a) . The data presented in this study have allowed us to refine our initial hypothesis: enhancement of the sI AHP is involved in age-related learning deficits. In support of our hypothesis, we have shown that nimodipine facilitates acquisition of the trace eyeblink conditioned response and reduces the AHP in animals (Deyo et al., 1989; Moyer et al., 1992; Kowalska and Disterhoft, 1994) . In this study, we have further shown that nimodipine reduces the sI AHP in young and aging animals. Similarly, chronic treatment with metrifonate, a cholinesterase inhibitor, or CI1017, an M1 muscarinic agonist, both reduce the sI AHP and the slow AHP and facilitate trace eyeblink conditioning in aging rabbits (Kronforst-Collins et al., 1997; Oh et al., 1999; Weiss et al., 2000; Power et al., 2001) . The cholinergic reduction of the sI AHP is independent of Ca 2ϩ entry (Muller and Connor, 1991) , suggesting that the cognitive benefits of procholinergic treatments are caused by a reduction of the sI AHP itself. We are unaware of experiments designed to disrupt learning by enhancing the sI AHP . However, treatment with the central cholinergic blocker scopolamine, which should eliminate cholinergic reduction of the sI AHP , disrupts trace eyeblink conditioning in young rabbits (Kaneko and Thompson, 1997) . The results of the present study provide additional support for an involvement of the enhanced sI AHP in age-related learning deficits, and further suggest that key modulators of this current are good candidates for future therapeutic interventions in age-related cognitive impairments.
